March 4, 2021
Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms
March 3, 2021
The Heart Failure Society of America (HFSA), the Heart Failure Association of the European Society of Cardiology (HFA-ESC) and the Japanese Heart Failure Society (JHFS) announced a new Universal Definition and Classification of Heart Failure, which will standardize language and practices around the definition and classification of heart failure (HF).
March 2, 2021
Contract Pricing Now Widely Available for the AcQMap® High Resolution 3D Imaging and Mapping System
March 2, 2021
Findings highlight need to better classify heart failure outcomes
February 25, 2021
Imricor Medical Systems, Inc. the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht University Medical Centre+ (MUMC+) in the Netherlands has commenced procedures since the extended lockdowns across Europe precluded elective surgeries. The team at MUMC+ successfully performed two atrial flutter ablations yesterday.
February 25, 2021
HeartLight® X3 System has significantly shorter procedure times for atrial fibrillation ablation
February 24, 2021
A transatlantic study collaboration between researchers from Canada and Germany has demonstrated that a wearable heart monitor device can significantly improve the detection of atrial fibrillation, a major risk factor for stroke.
February 22, 2021
A smart-alert study to guide anticoagulant treatment for patients with atrial fibrillation
February 22, 2021
RhythMedix, a leader in remote cardiac monitoring, announced the release of its next-generation RhythmStar® wearable device with built-in 4G cellular connectivity.
February 18, 2021
EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist Marina Izzo as Chief Executive Officer (CEO). Mrs. Izzo will set the vision for EBAMed’s technology and lead the effort for the next financing round, planned for 2022.